Basic fibroblast growth factor-mediated lymphangiogenesis of lymphatic endothelial cells isolated from dog thoracic ducts: Effects of heparin

Japanese Journal of Physiology

Volumn 48, Issue 2, 1998, Pages 133-141

  Tan, Yuzhen ^a   Ohhashi, Toshio ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

BFGF; Heparin; Lymphatic endothelial cells; Tube formation; Wound assay

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; HEPARIN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DOG; ELECTRON MICROSCOPY; FEMALE; LYMPH VESSEL ENDOTHELIUM; MALE; NONHUMAN; THORACIC DUCT; VASCULARIZATION;

ANIMALS; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; DOGS; ENDOTHELIUM; FEMALE; FIBROBLAST GROWTH FACTOR 2; HEPARIN; LYMPHATIC SYSTEM; MALE; MICROSCOPY, ELECTRON; THORACIC DUCT;

EID: 0031859052     PISSN: 0021521X     EISSN: None     Source Type: Journal    
DOI: 10.2170/jjphysiol.48.133     Document Type: Article

References (42)

1. Boucher Y, Baxter LT, and Jain RK: Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50 4478-4484, 1990
2. Jain RK. Transport of macromolecules in tumor microcirculation Biotechnol Prog 1. 81-84, 1985
3. Jain RK. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 9: 253-266, 1990
4. Pepper MS, Wasi S, Ferrara N, Orci L, and Montesano R. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells Exp Cell Res 210: 298-305, 1994
5. Ohhashi T, Fukushima S, and Azuma T: Vasa vasorum within the media of bovine mesenteric lymphatics Proc Soc Exp Biol Med (NY) 154: 582-586, 1977
6. Ohhashi T, Azuma T, and Sakaguchi M: Active and passive mechanical characteristics of bovine mesenteric lymphatics. Am J Physioi 239, H88-H95, 1980
7. Ohhashi T, Azuma T, and Sakaguchi M: Functional and structural characteristics of canine thoracic ducts. J Jpn Coll Angiol 22 109-116, 1982 (in Japanese)
8. Ohhashi T and Takahashi N: Acetylcholine-induced release of endothelium-derived relaxing factor from lymphatic endothelial cells Am J Physiol 260: H1172-H1178, 1991
9. Ohhashi T and Yokoyama S: Nitric oxide and the lymphatic system Jpn J Physiol 44: 327-342, 1994
10. Bikfalvi A, Klein S, Pintucci G, and Rifkin DB: Biological roles of fibroblast growth factor-2. Endocrine Rev 18: 26-45, 1997
11. Norrby K: Basic fibroblast growth factor and de novo mammalian angiogenesis. Microvasc Res 48. 96-113, 1994
12. Gospodarowicz D: Expression and control of vascular endothelial cells proliferation and differentiation by fibroblast growth factors J Invest Dermatol 93: 39S-47S, 1989
13. Klagsbrun M: Mediators of angiogenesis: the biological significance of basic fibroblast growth factor-heparin and heparan sulfate interactions. Cancer Biol 3: 81-87, 1992
14. Burgess WH and Maciag T. The heparin-binding growth factor family of proteins. Annu Rev Biochem 58: 575-606, 1989
15. Daum G, Hedin U, Wang Y, Wang T, and Clowes AW: Diverse effects of heparin on mitogen-activated protein kinase-dependent signal transduction in vascular smooth muscle cells. Circ Res 81: 17-23, 1997
16. Grainger DJ, Witchell CM, Watson JV, Metcalfe JC, and Weissberg PL: Heparin decreases the rate of proliferation of rat vascular smooth muscle cells by releasing transforming growth factor β-like activity from serum. Cardiovasc Res 27: 2238-2247, 1993
17. Sasisekharan R, Moses MA, Nugent MA, Cooney CL, and Langer R. Heparinase inhibits neovascularization. Proc Natl Acad Sci USA 91: 1524-1528, 1994
18. Gnepp DR and Chandler W: Tissue culture of human and canine thoracic duct endothelium. In Vitro Cell Dev Biol 21: 200-206, 1985
19. Poole JCF, Sanders AG, and Florey HW: The regeneration of aortic endothelium J Pathol Bactenol 75: 133-143, 1958
20. Sato Y and Rifkin DB: Autocrine activities of basic fibroblast growth factor. regulation activator synthesis, and DNA synthesis. J Cell Biol 107 1199-1205, 1988
21. Montesano R, Orci L, and Vassalli P: In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices. J. Cell Biol 97 1648-1652, 1983
22. Johnston MG and Walker MA: Lymphatic endothelial and smooth muscle cells in tissue culture. In Vitro Cell Dev Biol 20: 566-572, 1984
23. Jones BE and Yong LCJ Culture and characterization of bovine mesenteric endothelium. In Vitro Cell Dev Biol 23: 698-706, 1987
24. Leak LV and Jones M: Lymphatic endothelium isolation, characterization and long term culture. Anat Rec 236: 641-652, 1993
25. Jaffe EA, Hoyer LW, and Nachman RL: Synthesis of antihemophilic factor antigens by cultured human endothelial cells. J Clin Invest 52: 2757-2764, 1973
26. Voyta JC, Via DP, Butterfield CE, and Zetter BR: Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 99 2034-2040, 1984
27. Gospodarowicz D, Moran JS, Braun DL, and Birdwell C: Clonal growth of bovine vascular endothelial cells. fibroblast growth factors as a survival agent. Proc Natl Acad Sci USA 73 4120-4124, 1976
28. Gospodarowicz D and Bialecki H: The effect of the epidermal and fibroblast growth on the replicative lifespan of cultured bovine granulosa cells. Endocrinology 103. 854-860, 1978
29. Gospodarowicz D, Ferrara N, Schweigerer L, and Neufeld G: Structural characterization and biological functions of fibroblast growth factor. Endocrine Rev 8: 95-114, 1987
30. Leak LV and Jones M: Lymphangiogenesis in vitro, formation of lymphatic capillary-like channels from confluent monolayers of lymphatic endothelial cells. In Vitro Cell Dev Biol 30 512-518, 1994
31. Webb RC and Starzl TE: The effect of blood vessel pulsations on lymph pressure in large lymphatics. Bull Johns Hopkins Hosp 93: 401-407, 1953
32. Dvorak HF, Brown LF, Detmar M, and Dvorak AM. Vascular permeability factor/ vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146 1029-1039, 1995
33. Rouslathin E and Yamaguchi Y: Proteoglycans as modulators of growth factor activities Cell 64. 867-869, 1991 (minireview)
34. Folkman J and Shing Y: Angiogenesis J Biol Chem 267 10931-10934, 1992 (minireview)
35. Klagsbrun M and Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 67: 229-231, 1991 (minireview)
36. Letourneur D, Caleb BL, and Castellot JJ Jr. Heparin binding, internalization, and metabolism in vascular smooth muscle cells, I: upregulation of heparin binding correlates with antiproliferative activity. J Cell Physiol 165: 676-686, 1995
37. Clowes AW and Karnovsky MJ: Suppression by heparin of smooth muscle cell proliferation in injured arteries. Nature 265: 625-626, 1997
38. Geary RL, Koyama N, Wang TW, Vergel S, and Clowes AW: Failure of heparin to inhibit intimal hyperplasia in injured baboon arteries: the role of heparin-sensitive and -insensitive pathways in the stimulation of smooth muscle cell migration and proliferation. Circulation 91: 2927-2931, 1995
39. Nikkari ST, Jarvelainen HT, Wight TN, Ferguson M, and Clowes AW: Smooth muscle cell expression of extra-cellular matrix genes after arterial injury. Am J Pathol 144: 1348-1356, 1994
40. Kenagy RD, Nikkari ST, Welgus HG, and Clowes AW: Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 95-kD gelatinase, and collagenase) in primate arterial smooth muscle cells. J Clin Invest 93: 1987-1993, 1994
41. Pukac LA, Castellot JJ Jr, Wright TC Jr, Caleb BL, and Karnovsky MJ: Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regul 1: 435-443, 1990
42. Ottlinger ME, Pukac LA, and Karnovsky MJ: Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J Biol Chem 268: 19173-19176, 1993